Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024

April 22, 2024

https://www.globenewswire.com/news-release/2024/04/22/2866793/13009/en/Catalyst-Pharmaceuticals-to-Report-First-Quarter-2024-Financial-Results-on-May-8-2024.html

CORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq:CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it will release its first quarter 2024 financial results after the market close on Wednesday, May 8, 2024. Catalyst’s management team will host a conference call and webcast on Thursday, May 9, 2024, at 8:30 AM ET to discuss the Company’s financial results and provide a business update.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.